Open Access
Issue
Med Sci (Paris)
Volume 41, Number 2, Février 2025
Page(s) 133 - 135
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2025008
Published online 03 March 2025
  1. Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet 2024 ; 25 : 184–95. [CrossRef] [PubMed] [Google Scholar]
  2. El Masri R, Delon J. RHO GTPases: from new partners to complex immune syndromes. Nat Rev Immunol 2021 ; 21 : 499–513. [CrossRef] [PubMed] [Google Scholar]
  3. Donkó A, Sharapova SO, Kabat J, et al. Clinical and functional spectrum of RAC2-related immunodeficiency. Blood 2024 ; 143 : 1476–87. [CrossRef] [PubMed] [Google Scholar]
  4. Arrington ME, Temple B, Schaefer A, Campbell SL. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2. J Biol Chem 2020 ; 295 : 12130–42. [CrossRef] [PubMed] [Google Scholar]
  5. Doye A, Chaintreuil P, Lagresle-Peyrou C, et al. RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation. J Exp Med 2024 ; 221 : e20231562. [CrossRef] [PubMed] [Google Scholar]
  6. Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006 ; 16 : 522–529. [CrossRef] [PubMed] [Google Scholar]
  7. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002 ; 420 : 629–35. [CrossRef] [PubMed] [Google Scholar]
  8. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005 ; 15 : 163–71. [CrossRef] [PubMed] [Google Scholar]
  9. Boquet P, Lemichez E. Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis? Trends Cell Biol 2003 ; 13 : 238–46. [CrossRef] [PubMed] [Google Scholar]
  10. Stern H, Donkó A, Shapiro T, et al. A novel RAC2 variant presenting as severe combined immunodeficiency. J Clin Immunol 2021 ; 41 : 473–6. [CrossRef] [PubMed] [Google Scholar]
  11. Flatau G, Lemichez E, Gauthier M, et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997 ; 387 : 729–33. [CrossRef] [PubMed] [Google Scholar]
  12. Lerm M, Selzer J, Hoffmeyer A, et al. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 1999 ; 67 : 496–503. [CrossRef] [PubMed] [Google Scholar]
  13. Boyer L, Magoc L, Dejardin S, et al. Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway. Immunity 2011 ; 35 : 536–49. [CrossRef] [PubMed] [Google Scholar]
  14. Dufies O, Doye A, Courjon J, et al. Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice. Nat Microbiol 2021 ; 6 : 401–12. [CrossRef] [PubMed] [Google Scholar]
  15. Dufies O, Boyer L. RhoGTPases and inflammasomes: Guardians of effector-triggered immunity. PLoS Pathog 2021 ; 17 : e1009504. [CrossRef] [PubMed] [Google Scholar]
  16. Shao F. Gasdermins: making pores for pyroptosis. Nat Rev Immunol 2021 ; 21 : 620–1. [CrossRef] [PubMed] [Google Scholar]
  17. Fu J, Schroder K, Wu H. Mechanistic insights from inflammasome structures. Nat Rev Immunol 2024 ; 24 : 518–35. [CrossRef] [PubMed] [Google Scholar]
  18. Kayagaki N, Kornfeld OS, Lee BL, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 2021 ; 591 : 131–6. [CrossRef] [PubMed] [Google Scholar]
  19. Nishitani-Isa M, Mukai K, Honda Y, et al. Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation. J Exp Med 2022 ; 219 : e20211889. [CrossRef] [PubMed] [Google Scholar]
  20. Spel L, Zaffalon L, Hou C, et al. CDC42 regulates PYRIN inflammasome assembly. Cell Rep 2022 ; 41 : 111636. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.